DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: pharmaceutical industry India

News

India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

01.06.2013 - India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with...

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

27.03.2013 - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...

News

Slow Approvals Put India's Drug Trials Industry at Risk

13.02.2013 - Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...

News

GSK Spends $900 Million to Lift Stake in India Consumer Arm

05.02.2013 - GlaxoSmithKline has lifted its stake in its publicly-listed Indian consumer healthcare subsidiary to 72.5% from 43.2%, deepening its footprint in emerging markets and non...

News

Bayer Sues Lupin Over Generic Birth Control Pill

30.11.2012 - German drugmaker Bayer has filed a lawsuit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth control pill Natazia...

News

Ranbaxy Halts Generic Lipitor Production After Recall

30.11.2012 - Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent...

News

GSK to Raise India Unit Stake in $940 Million Deal

26.11.2012 - GlaxoSmithKline plans to buy up to an additional 31.8% stake in its Indian consumer products arm for about $940 million, as Britain's biggest drugmaker deepens its emerging markets...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.